187 related articles for article (PubMed ID: 11078933)
1. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat.
Cui CL; Wu LZ; Han JS
Neurosci Lett; 2000 Dec; 295(1-2):45-8. PubMed ID: 11078933
[TBL] [Abstract][Full Text] [Related]
2. Antinociceptive effects of morphine and U-50,488H on vaginal distension in the anesthetized rat.
Friese N; Diop L; Lambert C; Rivière PJ; Dahl SG
Life Sci; 1997; 61(16):1559-70. PubMed ID: 9353165
[TBL] [Abstract][Full Text] [Related]
3. The role of nitric oxide in the development of opioid withdrawal induced by naloxone after acute treatment with mu- and kappa-opioid receptor agonists.
Capasso A; Sorrentino L; Pinto A
Eur J Pharmacol; 1998 Oct; 359(2-3):127-31. PubMed ID: 9832382
[TBL] [Abstract][Full Text] [Related]
4. Effects of differential modulation of mu-, delta- and kappa-opioid systems on bicuculline-induced convulsions in the mouse.
Yajima Y; Narita M; Takahashi-Nakano Y; Misawa M; Nagase H; Mizoguchi H; Tseng LF; Suzuki T
Brain Res; 2000 Apr; 862(1-2):120-6. PubMed ID: 10799676
[TBL] [Abstract][Full Text] [Related]
5. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
Beadles-Bohling AS; Wiren KM
Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153
[TBL] [Abstract][Full Text] [Related]
6. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
Ko MC; Lee H; Song MS; Sobczyk-Kojiro K; Mosberg HI; Kishioka S; Woods JH; Naughton NN
J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal contractures of guinea-pig isolated ileum after acute activation of kappa-opioid receptors.
Morrone LA; Romanelli L; Amico MC; Valeri P
Br J Pharmacol; 1993 May; 109(1):48-52. PubMed ID: 8388301
[TBL] [Abstract][Full Text] [Related]
8. Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria.
Raffa RB; Baron DA; Tallarida RJ
Eur J Pharmacol; 2006 Jul; 540(1-3):200-1. PubMed ID: 16737694
[TBL] [Abstract][Full Text] [Related]
9. Prodynorphin gene deficiency potentiates nalbuphine-induced behavioral sensitization and withdrawal syndrome in mice.
Shin EJ; Jang CG; Bing G; Park DH; Oh CH; Koo KH; Oh KW; Yamada K; Nabeshima T; Kim HC
Drug Alcohol Depend; 2009 Sep; 104(1-2):175-84. PubMed ID: 19559544
[TBL] [Abstract][Full Text] [Related]
10. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
11. Different roles of mu-, delta- and kappa-opioid receptors in ethanol-associated place preference in rats exposed to conditioned fear stress.
Matsuzawa S; Suzuki T; Misawa M; Nagase H
Eur J Pharmacol; 1999 Feb; 368(1):9-16. PubMed ID: 10096764
[TBL] [Abstract][Full Text] [Related]
12. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
Nazarian A; Krall CM; Osburn JR; McDougall SA
Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
[TBL] [Abstract][Full Text] [Related]
13. The kappa-opioid receptor agonist U50,488H induces acute physical dependence in guinea-pigs.
Brent PJ; Chahl LA; Cantarell PA; Kavanagh C
Eur J Pharmacol; 1993 Sep; 241(2-3):149-56. PubMed ID: 7902288
[TBL] [Abstract][Full Text] [Related]
14. Role of spinal kappa opioid receptors in the blockade of the development of antinociceptive tolerance to morphine.
Takahashi M; Senda T; Kaneto H
Eur J Pharmacol; 1991 Aug; 200(2-3):293-7. PubMed ID: 1664330
[TBL] [Abstract][Full Text] [Related]
15. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
Sinchaisuk S; Ho IK; Rockhold RW
Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
[TBL] [Abstract][Full Text] [Related]
16. Protracted withdrawal from ethanol and enhanced responsiveness stress: regulation via the dynorphin/kappa opioid receptor system.
Gillett K; Harshberger E; Valdez GR
Alcohol; 2013 Aug; 47(5):359-65. PubMed ID: 23731692
[TBL] [Abstract][Full Text] [Related]
17. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
[TBL] [Abstract][Full Text] [Related]
18. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
Takemori AE; Schwartz MM; Portoghese PS
J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
[TBL] [Abstract][Full Text] [Related]
19. Kappa-opioid receptor-mediated antinociception in the rat. II. Supraspinal in addition to spinal sites of action.
Millan MJ; Członkowski A; Lipkowski A; Herz A
J Pharmacol Exp Ther; 1989 Oct; 251(1):342-50. PubMed ID: 2571723
[TBL] [Abstract][Full Text] [Related]
20. Involvement of kappa-opioid receptor mechanisms in the calcitonin-induced potentiation of opioid effects at the hypothalamus-pituitary-adrenocortical axis.
Milanés MV; Vargas ML; Martín MI
Eur J Pharmacol; 1994 Dec; 271(1):103-9. PubMed ID: 7698193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
